Edgewell Personal Care Company: Wells Fargo Raises Target Price to $32 From $30
EPC•Related News
vTv Therapeutics Q2 FY26 net loss widens to $13.1 million; R&D expenses more than doubled to $8.8 million
VTVT•
Aligos Q2 FY26 net loss narrows 91% to $1.5 million
ALGS•
MBX Biosciences Q2 FY26 net loss widens to $37.1 million; R&D expenses rise to $31 million
MBX•
Establishment Labs Q2 revenue rises, beats estimates
ESTA•
Ralph Lauren beats quarterly revenue estimates
RL•